Dorry L Segev

Author PubWeight™ 169.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 2014 7.25
2 Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011 6.72
3 Association of race and age with survival among patients undergoing dialysis. JAMA 2011 5.82
4 Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010 5.72
5 Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med 2015 5.03
6 Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013 3.82
7 Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010 2.75
8 Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet 2006 2.38
9 Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation 2014 2.26
10 Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 2005 2.15
11 Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology 2011 2.07
12 Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc 2013 2.06
13 Candidacy for kidney transplantation of older adults. J Am Geriatr Soc 2012 1.85
14 Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis 2012 1.82
15 Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology 2007 1.82
16 A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med 2009 1.81
17 The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011 1.79
18 Caroli's disease and outcomes after liver transplantation. Liver Transpl 2008 1.78
19 Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation 2012 1.78
20 ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009 1.71
21 Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups. Clin Transplant 2011 1.64
22 Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation 2014 1.62
23 Live donor champion: finding live kidney donors by separating the advocate from the patient. Transplantation 2012 1.60
24 Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis 2010 1.58
25 Cumulative incidence of cancer after solid organ transplantation. Cancer 2013 1.58
26 Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation 2012 1.55
27 Trends in kidney transplant outcomes in older adults. J Am Geriatr Soc 2014 1.53
28 Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012 1.52
29 Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl 2007 1.51
30 Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation 2015 1.45
31 Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol 2011 1.45
32 Impact of broader sharing on the transport time for deceased donor livers. Liver Transpl 2014 1.41
33 Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates. Am J Kidney Dis 2011 1.41
34 The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization. Am J Kidney Dis 2010 1.39
35 Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation 2008 1.35
36 The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol 2010 1.32
37 A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant 2005 1.32
38 Frailty and delayed graft function in kidney transplant recipients. Arch Surg 2012 1.30
39 Living unrelated renal transplantation: a good match for the pediatric candidate? J Pediatr Surg 2013 1.30
40 Kidney transplantation in the elderly. Semin Nephrol 2009 1.27
41 Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol 2007 1.25
42 Vascular disease, ESRD, and death: interpreting competing risk analyses. Clin J Am Soc Nephrol 2012 1.23
43 Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation 2014 1.22
44 Liver sharing and organ procurement organization performance. Liver Transpl 2015 1.21
45 Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006 1.14
46 Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity. Transplantation 2015 1.12
47 Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 2011 1.12
48 National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 2014 1.11
49 Trends in the timing of pre-emptive kidney transplantation. J Am Soc Nephrol 2011 1.10
50 Kidney paired donation: fundamentals, limitations, and expansions. Am J Kidney Dis 2011 1.06
51 C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2008 1.04
52 Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation 2014 1.04
53 Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg 2009 1.04
54 National trends in surgical procedures for hepatocellular carcinoma: 1998-2008. Cancer 2011 1.04
55 Age at graft loss after pediatric kidney transplantation: exploring the high-risk age window. Clin J Am Soc Nephrol 2013 1.03
56 Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med 2008 0.99
57 Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol 2012 0.98
58 Incompatible live-donor kidney transplantation in the United States: results of a national survey. Clin J Am Soc Nephrol 2011 0.97
59 Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells. Mol Cell Endocrinol 2003 0.96
60 New options for patients with donor incompatibilities. Transplantation 2006 0.96
61 Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients. Transplantation 2013 0.95
62 The diagnosis of acute appendicitis in a pediatric population: to CT or not to CT. J Pediatr Surg 2003 0.92
63 National assessment of early biliary complications following liver transplantation: incidence and outcomes. Liver Transpl 2014 0.91
64 Preemptive deceased donor kidney transplantation: considerations of equity and utility. Clin J Am Soc Nephrol 2013 0.91
65 Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation 2015 0.90
66 Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients. J Am Soc Nephrol 2008 0.90
67 The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005 0.90
68 Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol 2012 0.89
69 Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction. Transplantation 2017 0.87
70 Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Liver Transpl 2009 0.87
71 Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data. Am J Nephrol 2014 0.86
72 Order of donor type in pediatric kidney transplant recipients requiring retransplantation. Transplantation 2013 0.86
73 Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors. Liver Transpl 2009 0.86
74 Health outcomes among non-Caucasian living kidney donors: knowns and unknowns. Transpl Int 2013 0.85
75 Potential limitations of presumed consent legislation. Transplantation 2012 0.85
76 The high-risk donor: viral infections in solid organ transplantation. Curr Opin Organ Transplant 2008 0.85
77 Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease. Transplantation 2016 0.84
78 Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients. Transplantation 2016 0.84
79 Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation 2015 0.84
80 Activity of daily living disability and dialysis mortality: better prediction using metrics of aging. J Am Geriatr Soc 2012 0.84
81 Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation 2013 0.84
82 Successful transplantation of cadaveric polycystic liver: case report and review of the literature. Transplantation 2006 0.84
83 Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Mol Endocrinol 2006 0.83
84 Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation. Arch Surg 2011 0.83
85 Recipient age and time spent hospitalized in the year before and after kidney transplantation. Transplantation 2012 0.83
86 Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture. Ann Hepatol 2013 0.82
87 Kidney Transplants from HLA-Incompatible Live Donors and Survival. N Engl J Med 2016 0.82
88 Surgical management of early and late ureteral complications after renal transplantation: techniques and outcomes. Clin Transplant 2014 0.82
89 Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants. Transplantation 2014 0.81
90 Renal Transplantation in HIV-Positive Recipients. Curr Infect Dis Rep 2010 0.81
91 Survival Benefit of Kidney Transplantation in HIV-infected Patients. Ann Surg 2016 0.81
92 Better understanding live donor risk through big data. Clin J Am Soc Nephrol 2013 0.81
93 Role of MDCT angiography in selection and presurgical planning of potential renal donors. AJR Am J Roentgenol 2012 0.81
94 Gout after living kidney donation: correlations with demographic traits and renal complications. Am J Nephrol 2015 0.80
95 High infectious risk donors: what are the risks and when are they too high? Curr Opin Organ Transplant 2011 0.80
96 Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients. Am J Kidney Dis 2012 0.80
97 Center-level variation in the development of delayed graft function after deceased donor kidney transplantation. Transplantation 2015 0.80
98 HLA incompatible renal transplantation. Curr Opin Organ Transplant 2012 0.80
99 National assessment of early biliary complications after liver transplantation: economic implications. Transplantation 2014 0.79
100 Volumes of liver transplant and partial hepatectomy procedures are independently associated with lower postoperative mortality following resection for hepatocellular carcinoma. Liver Transpl 2009 0.79
101 Where the Sun Shines: Industry's Payments to Plastic Surgeons. Plast Reconstr Surg 2015 0.79
102 International kidney paired donation. Transplantation 2013 0.79
103 The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib. Clin Transpl 2009 0.79
104 ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Liver Transpl 2009 0.79
105 Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience. Arch Surg 2011 0.78
106 Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature. Clin Transplant 2011 0.78
107 New developments in geriatric surgery. Curr Probl Surg 2011 0.78
108 Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality. Transplantation 2015 0.78
109 Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Cardiovasc Pathol 2010 0.78
110 Race is a predictor of in-hospital mortality after cholecystectomy, especially in those with portal hypertension. Clin Gastroenterol Hepatol 2008 0.78
111 Late graft loss among pediatric recipients of DCD kidneys. Clin J Am Soc Nephrol 2011 0.78
112 Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. J Am Geriatr Soc 2014 0.77
113 From Bench to Bill: How a Transplant Nuance Became 1 of Only 57 Laws Passed in 2013. Ann Surg 2016 0.77
114 Blood dendritic cell levels associated with impaired IL-12 production and T-cell deficiency in patients with kidney disease: implications for post-transplant viral infections. Transpl Int 2014 0.77
115 Operative start times and complications after kidney transplantation. Clin Transplant 2012 0.77
116 Living donor kidney exchange. Clin Transpl 2011 0.77
117 Actual and perceived knowledge of kidney transplantation and the pursuit of a live donor. Transplantation 2014 0.77
118 Outcomes and discard of kidneys from pediatric donors after cardiac death. Transplantation 2011 0.76
119 Translational research in surgical disease. Arch Surg 2010 0.76
120 HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant 2013 0.76
121 Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation. Transplantation 2016 0.76
122 Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy. Liver Transpl 2015 0.76
123 The application of paired donation to live donor liver transplantation. Liver Transpl 2010 0.76
124 Virtual populations, real decisions: making sense of stochastic simulation studies. Transplantation 2015 0.75
125 Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes. Transplantation 2016 0.75
126 Living kidney donors and their family caregivers: developing an evidence-based educational and social support website. Prog Transplant 2012 0.75
127 The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery. Ann Plast Surg 2017 0.75
128 Fast-tracking and fairness: getting organ offers quickly to candidates who will accept them. Liver Transpl 2013 0.75
129 Transplantation: Alloantibodies in simultaneous liver-kidney transplantation. Nat Rev Nephrol 2013 0.75
130 The authors' reply. Transplantation 2014 0.75
131 Individual Frailty Components and Mortality In Kidney Transplant Recipients. Transplantation 2016 0.75
132 Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation 2016 0.75
133 Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation. Transplantation 2016 0.75
134 Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study. Ann Surg 2016 0.75
135 Influencing public policy to improve the lives of older Americans. Gerontologist 2010 0.75
136 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017 0.75
137 Mortality and Graft Loss Attributable to Readmission following Kidney Transplantation: Immediate and Long-Term Risk. Transplantation 2016 0.75
138 Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors. Ann Surg 2017 0.75
139 Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation 2017 0.75
140 The Right Organ for the Right Recipient: the Ninth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Clin Transplant 2011 0.75
141 A New Culture of Transparency: Industry Payments to Orthopedic Surgeons. Orthopedics 2016 0.75
142 Deceased-donor liver size and the sex-based disparity in liver transplantation. Transplantation 2017 0.75
143 Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr 2017 0.75
144 Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017 0.75
145 Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35. Transplantation 2019 0.75
146 Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States. Transplantation 2017 0.75
147 Frailty and Postkidney Transplant Health-Related Quality of Life. Transplantation 2017 0.75
148 Survey of current practice related to grading of rejection in cardiac transplant recipients in North America. Cardiovasc Pathol 2010 0.75
149 Controversies in kidney paired donation. Adv Chronic Kidney Dis 2012 0.75